Last reviewed · How we verify
NCT03247049: ICHCat
Prognosis in Intracerebral Hemorrhage. The ICHCat Score in Primary Care.
trial in Intracerebral Hemorrhage in 262 participants. Completed in 28 July 2017.
31 December 2016
Quick facts
| Lead sponsor | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 262 |
| Start date | 27 July 2015 |
| Primary completion | 31 December 2016 |
| Estimated completion | 28 July 2017 |
Conditions studied
- Intracerebral Hemorrhage — all drugs for Intracerebral Hemorrhage →
- Outcome — all drugs for Outcome →
- Survival — all drugs for Survival →
- Primary Care — all drugs for Primary Care →
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina — full company profile →
Who can join
Adults 15 to 90, any sex, with Intracerebral Hemorrhage or Outcome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The clinical evidence shows that patients with a first episode of intracerebral hemorrhage (ICH) are increasingly old and with greater comorbidity with a recognized impact over mortality. The prediction of the outcome of ICH is not only crucial in the emergin attention to identify those patients with favorable criteria that can benefit from possible treatments; but also after hospital discharge, in primary care where the prediction should facilitate the organization and management of a wide variety of resources: familiar, health and social welfare. Even though there are different scales that predict mortality, these are not sufficiently useful in choosing a treatment or do not provide sufficient data to the family to decide. Due to the characteristics of the population with ICH described in these works, it seems useful to propose a prognostic index (ICHCat) to identify the variables associated to its incidence and mortality and that, in addition, to make adjustments in the comparisons of the survival between different series of patients or different treatment modalities in primary care.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Complex chronic patients as an emergent group with high risk of intracerebral haemorrhage: an observational cohort study.
Lorman-Carbó B, Clua-Espuny JL, Muria-Subirats E, Ballesta-Ors J, et al · · 2021 · cited 3× · PMID 33546615 · DOI 10.1186/s12877-021-02004-4 -
Risk of Long-Term Mortality for Complex Chronic Patients with Intracerebral Hemorrhage: A Population-Based e-Cohort Observational Study.
González-Henares MA, Clua-Espuny JL, Lorman-Carbo B, Fernández-Saez J, et al · · 2020 · cited 3× · PMID 31879838 · DOI 10.1007/s12325-019-01206-y -
European Stroke Organisation Conference: Abstracts
· 2018
Verify or expand the search:
- PubMed search for NCT03247049
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intracerebral Hemorrhage
Currently open trials in the same condition.
- NCT07458880 — Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control · NA · recruiting
- NCT07365150 — Precision Use of TXA in Intracerebral Hemorrhage · NA · recruiting
- NCT07246473 — Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage · NA · recruiting
- NCT07455201 — Evaluating a Prototype CT Scan for ICH Evacuation · NA · recruiting
- NCT07187687 — TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage · NA · recruiting
Other Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina trials
Trials by the same sponsor.
- NCT07441759 — throMboembolic Risk Associated To High atrIal Fibrillation riSk · not yet recruiting
- NCT07132632 — Effect of a Multicomponent Therapeutic Exercise Program in Primary Care on Frailty and Sarcopenia in Older Adults · NA · not yet recruiting
- NCT07373119 — Improving Frailty in Patients With Stable Ischemic Heart Disease · NA · enrolling by invitation
- NCT06581367 — Tailoring Antibiotic Duration for Respiratory Tract Infections in Primary Care · Phase 4 · not yet recruiting
- NCT06988904 — ENERGY2MOB STUDY: OBESITY MANAGEMENT IN BERGUEDÀ · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03247049 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- Last refreshed: 16 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03247049.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing